COMBINATIONS OF DICLOFENAC AND H2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN AND INFLAMMATION

• 收藏
• 分享

专利权人:

Mehmet Nevzat PISAK

发明人:

Mehmet Nevzat PISAK

申请号：

US16465862

公开号：

US20190307713A1

申请日:

2017.12.07

申请国别(地区):

US

年份:

2019

代理人:

摘要：

A single unit pharmaceutical dosage form comprising: diclofenac or a pharmaceutically acceptable salt thereof； and an H2 receptor antagonist, preferably famotidine or a pharmaceutically acceptable salt thereof, wherein diclofenac has a Tmax of between about and 50 minutes after administering said formulation to a patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/